The EPIC-Norfolk Study

 

Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention.

Hoogeveen RM, Pereira JPB, Nurmohamed NS, Zampoleri V, Bom MJ, Baragetti A, Boekholdt SM, Knaapen P, Khaw KT, Wareham NJ, Groen AK, Catapano AL, Koenig W, Levin E, and Stroes ESG

European heart journal. Nov 2019

(DOI : 10.1093/eurheartj/ehaa648)

---

Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting.

Verbeek R, Hoogeveen RM, Langsted A, Stiekema LCA, Verweij SL, Hovingh GK, Wareham NJ, Khaw KT, Boekholdt SM, Nordestgaard BG, and Stroes ESG

European heart journal. Oct 2017

(DOI : 10.1093/eurheartj/ehy334)

---